Bank Of New York Mellon Corp Aura Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$8.88 - $12.11 $574,171 - $783,020	64,659 New	64,659 $600 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $493,946 - $730,900	50,096 New	50,096 $526,000
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $134,144 - $208,281	10,240 Added 25.54%	50,336 $912,000
Q2 2022 Aug 15, 2022	BUY	$12.37 - $21.86 $316,672 - $559,616	25,600 Added 176.6%	40,096 $569,000
Q1 2022 May 11, 2022	BUY	$15.94 - $23.34 $231,066 - $338,336	14,496 New	14,496 $319,000

37.6M

122K

38.5K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $231M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.